Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,195,589
-
Share change
-
-577,175
-
Total reported value
-
$1,494,550
-
Price per share
-
$1.25
-
Number of holders
-
19
-
Value change
-
-$493,306
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2023
As of 31 Dec 2023,
Lexaria Bioscience Corp. - COM NEW (LEXX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,195,589 shares.
The largest 10 holders included
Invenomic Capital Management LP, COWEN AND COMPANY, LLC, Connective Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), UBS Group AG, 1832 Asset Management L.P., and ADAR1 Capital Management, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.